IDH2 and central nervous system cancer: We performed methylome profiling of glioma tissues (GBM WHO IV) and the primary GBM cells derived from the tissues were characterized for the mutational status of IDH1/IDH2 and methylation of MGMT (Table 1) as described in Materials and Methods.